Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Polaris joins existing backers for I-Therapeutix's third round

Executive Summary

New investor Polaris Venture Partners led a $15mm Series C financing for I-Therapeutix and contributed a new board member to the company, which uses hydrogel technology to create surgical sealants for wounds on the eye. Returning backers Versant Ventures and SV Life Sciences also participated. The proceeds will go towards US marketing of I-Zip, a synthetic bandage used during ocular surgery, and developing sustained-release ophthalmic drug delivery devices.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Medical Devices
    • Biomaterials
    • Surgical Equipment & Devices
      • Surgical Sealants
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies